Legal Representation
Attorney
Anne E. Naffziger
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 5, 2017 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jun 5, 2017 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Apr 26, 2017 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Nov 3, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 3, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 3, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 2, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 29, 2016 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 28, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 26, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals and pharmaceutical preparations for treatment and diagnosis of various diseases and conditions
First Use Anywhere:
Jun 27, 2016
First Use in Commerce:
Jun 27, 2016
Additional Information
Design Mark
The mark consists of the words "Sonoma Pharmaceuticals" with two intersecting helical lines to the left of the wording.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"